Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1995 493
1996 8
1997 8
1998 10
1999 4
2000 9
2001 3
2002 6
2003 6
2004 5
2005 6
2006 2
2007 6
2009 3
2010 8
2011 6
2012 2
2013 7
2014 8
2015 9
2016 4
2017 5
2018 4
2019 5
2020 3
Text availability
Article attribute
Article type
Publication date

Search Results

619 results
Results by year
Filters applied: . Clear all
Page 1
Trilateral retinoblastoma: a systematic review and meta-analysis.
de Jong MC, Kors WA, de Graaf P, Castelijns JA, Kivelä T, Moll AC. de Jong MC, et al. Lancet Oncol. 2014 Sep;15(10):1157-67. doi: 10.1016/S1470-2045(14)70336-5. Epub 2014 Aug 7. Lancet Oncol. 2014. PMID: 25126964 Review.
Before 1995, no patients with non-pineal trilateral retinoblastoma survived, but from 1995 onwards, 5-year survival was 57% (30-77; p=0·035). ...Non-pineal trilateral retinoblastomas were larger than pineal tumours (median 30 mm [range 6-100] vs 22 mm [7-60]; …
Before 1995, no patients with non-pineal trilateral retinoblastoma survived, but from 1995 onwards, 5-year survival was 57% (3 …
Expression of delta-like protein 3 is reproducibly present in a subset of small cell lung carcinomas and pulmonary carcinoid tumors.
Xie H, Boland JM, Maleszewski JJ, Aubry MC, Yi ES, Jenkins SM, Koepplin JW, Terra SBSP, Mansfield AS, Roden AC. Xie H, et al. Lung Cancer. 2019 Sep;135:73-79. doi: 10.1016/j.lungcan.2019.07.016. Epub 2019 Jul 17. Lung Cancer. 2019. PMID: 31447005
OBJECTIVES: Delta-like protein 3 (DLL3), an inhibitory Notch ligand, is the target for rovalpituzumab tesirine in development for the treatment of small cell lung cancer (SCLC). ...MATERIALS AND METHODS: Institutional pathology files were searched for resected pulmonary ne …
OBJECTIVES: Delta-like protein 3 (DLL3), an inhibitory Notch ligand, is the target for rovalpituzumab tesirine in development for the treatm …
T-cell/histiocyte-rich B-cell lymphoma: Clinical presentation, management and prognostic factors: report on 61 patients and review of literature.
El Weshi A, Akhtar S, Mourad WA, Ajarim D, Abdelsalm M, Khafaga Y, Bazarbashi S, Maghfoor I. El Weshi A, et al. Leuk Lymphoma. 2007 Sep;48(9):1764-73. doi: 10.1080/10428190701559124. Leuk Lymphoma. 2007. PMID: 17786712 Review.
T-cell/histiocyte-rich B-cell lymphoma (TC/HRBCL) is a rare subtype of diffuse large B-cell non-Hodgkin's lymphoma (DLBCL) with characteristic morphologic and immunophenotypic features, often misdiagnosed as Hodgkin's lymphoma and peripheral T-cell lym …
T-cell/histiocyte-rich B-cell lymphoma (TC/HRBCL) is a rare subtype of diffuse large B-cell non-Hodgkin's lymphoma (DLB …
Nasopharyngeal/nasal type NK/T lymphoma: analysis of 23 cases and current review of the literature.
Youssef YB, Bougmiza I, Bouabid Z, Achour B, Regaieg H, Sriha B, Belkadhi M, Omri HE, Khelif A. Youssef YB, et al. Kulak Burun Bogaz Ihtis Derg. 2012 Sep-Oct;22(5):275-83. doi: 10.5606/kbbihtisas.2012.053. Kulak Burun Bogaz Ihtis Derg. 2012. PMID: 22991988 Review.
PATIENTS AND METHODS: Computed tomography and biopsy results of 23 patients (15 males, 8 females; mean age 41 years; range 22 to 72 years) with extranodal NK/T-cell lymphoma who were treated at the department of clinical hematology between 1995 and 2011 were …
PATIENTS AND METHODS: Computed tomography and biopsy results of 23 patients (15 males, 8 females; mean age 41 years; range 22 to 72 y …
Neutropenia in the neonate.
al-Mulla ZS, Christensen RD. al-Mulla ZS, et al. Clin Perinatol. 1995 Sep;22(3):711-39. Clin Perinatol. 1995. PMID: 8521690 Review.
Contribution of chromosome 9p21-22 deletion to the progression of human renal cell carcinoma.
Kinoshita H, Yamada H, Ogawa O, Kakehi Y, Osaka M, Nakamura E, Mishina M, Habuchi T, Takahashi R, Sugiyama T, et al. Kinoshita H, et al. Jpn J Cancer Res. 1995 Sep;86(9):795-9. doi: 10.1111/j.1349-7006.1995.tb03087.x. Jpn J Cancer Res. 1995. PMID: 7591954 Free PMC article.
To investigate the possible role of genomic aberrations of chromosome 9p21-22 in the tumorigenesis of human renal cell carcinoma (RCC), 10 RCC cell lines, 55 primary RCCs and 5 metastatic lesions were studied by Southern blotting and polymerase chain reaction …
To investigate the possible role of genomic aberrations of chromosome 9p21-22 in the tumorigenesis of human renal cell carcino …
The emerging molecular genetics of sarcoma translocations.
Ladanyi M. Ladanyi M. Diagn Mol Pathol. 1995 Sep;4(3):162-73. doi: 10.1097/00019606-199509000-00003. Diagn Mol Pathol. 1995. PMID: 7493135 Review.
Furthermore, six of the translocations, namely the t(11;22), t(21;22), and t(7;22) of Ewing's sarcoma, the t(12;22) of clear cell sarcoma, the t(12;16) of myxoid liposarcoma, and the t(11;22) of desmoplastic small round cell tumor, …
Furthermore, six of the translocations, namely the t(11;22), t(21;22), and t(7;22) of Ewing's sarcoma, the t(12;22
Hemolytic anemia in the newborn.
Matsunaga AT, Lubin BH. Matsunaga AT, et al. Clin Perinatol. 1995 Sep;22(3):803-28. Clin Perinatol. 1995. PMID: 8521694 Review.
Evaluation of hemolytic anemia in the newborn may be complicated owing to the physiologic changes that occur during this time; however, the newborn period is a time when congenital red cell abnormalities may first present and when maternal factors need to be considered. .. …
Evaluation of hemolytic anemia in the newborn may be complicated owing to the physiologic changes that occur during this time; however, the …
Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial.
Canfell K, Caruana M, Gebski V, Darlington-Brown J, Heley S, Brotherton J, Gertig D, Jennett CJ, Farnsworth A, Tan J, Wrede CD, Castle PE, Saville M. Canfell K, et al. PLoS Med. 2017 Sep 19;14(9):e1002388. doi: 10.1371/journal.pmed.1002388. eCollection 2017 Sep. PLoS Med. 2017. PMID: 28926579 Free PMC article. Clinical Trial.
A total of 5,006 eligible women were recruited from 29 October 2013 to 7 November 2014 (recruitment rate 58%); of these, 22% were in the group age-eligible for vaccination. ...
A total of 5,006 eligible women were recruited from 29 October 2013 to 7 November 2014 (recruitment rate 58%); of these, 22% were in …
Multimodality imaging of osteomyelitis.
Elgazzar AH, Abdel-Dayem HM, Clark JD, Maxon HR 3rd. Elgazzar AH, et al. Eur J Nucl Med. 1995 Sep;22(9):1043-63. doi: 10.1007/BF00808418. Eur J Nucl Med. 1995. PMID: 7588943 Review.
The use of different imaging modalities in the diagnosis of special forms of osteomyelitis, including chronic, diabetic foot, and vertebral osteomyelitis, and osteomyelitis associated with orthopedic appliances and sickle cell disease is reviewed. ...
The use of different imaging modalities in the diagnosis of special forms of osteomyelitis, including chronic, diabetic foot, and vertebral …
619 results
Jump to page
Feedback